TARIQ F. AZIZ **** Keller Parkway, Apt. ****, Keller, TX 76248 • 404-***-**** • adqxuw@r.postjobfree.com, page 1 PROFILE

Accomplished growth executive with proven success in General Management, Strategy, M&A, Business Development and New Markets Development. Diversified global over 15 years of experience in Ophthalmology. Track record of creating economic value by driving profitable incremental revenue, while strengthening competitive position. Proven leadership domestically and internationally with demonstrated strengths in Pharmaceutical, Diagnostics and Medical Devices. PROFESSIONAL EXPERIENCE

SOUTHLAKE VENTURES, LLC, Dallas/Fort Worth, TX 2020 – present Managing Partner

Southlake Ventures makes direct investments and provides strategic and execution oriented advisory services to startups and early stage companies actively looking to develop organic and inorganic growth strategies in the pharmaceutical, medical device and life sciences industries.

Key advisory services include: Strategic analysis, Corporate Business Development, Licensing, M&A, Capital raising, Strategic landscape assessments and Direct equity investments BERG HEALTH, Boston, MA 2018 - 2020

Berg is a Framingham-based biopharma startup focused on taking a bold approach to developing drugs using the AI-based Interrogative Biology® platform to engage the differences in biology between healthy and disease environments as a foundation to driving a Precision Medicine paradigm. Lead assets in oncology entering mid and late stage trials in solid tumor, dermatology and skin cancer, combined with a portfolio in endocrinology, CNS diseases, and cancer diagnostics. Vice President, Corporate Business Development and Corporate Strategy Reported to Chief Business officer

• Head for Corporate business strategy, business development, Partnerships and alliance management activities for Berg.

• Lead for opportunity scouting, identification, business case development, transaction planning, analysis, negotiation, and execution, based on unmet needs for all forms of acquisitions including in/out-licensing, joint ventures, co-promotions, co- development, partnerships, distribution agreements, and acquisitions. Integral part of capital raising process. ATRION CORPORATION, Dallas, TX 2012 – 2018

Manufacturer of innovative medical devices within Cardiovascular, Ophthalmic and Fluid Delivery with market capitalization of + $1.0 B. Led a team of 6 direct reports and multiple number of cross functional indirect reports. Corporate Vice President, Corporate Business Development, Strategy and Marketing and Sales Reported to Chairman and CEO. Member of Atrion’s executive management team. Responsible for all aspects of marketing and sales, streamlining current business operations and developing new business through alliances, partnerships and M&A.

• Spearheaded P&L for $100 million business unit consisting of Cardiovascular, Ophthalmology and Fluid delivery medical devices and consumables. Streamlined current portfolio, restructured business operations, product pricing and clinical claims to effectively compete with competitors. Achieved growth of over 10% per year while launching new innovative products. Managed all key accounts and relationships including Mayo Clinic, MD Anderson, Emory and Duke medical.

• Developed annual strategic plan to drive global growth in key markets, including new product development initiatives. Expanded North American and international distribution by creating alliances and partnerships with regional players.

• Evaluated multiple M&A opportunities and conducted in depth due diligence within Cardiovascular and Ophthalmic businesses. Licensed IP to develop innovative new products and captured market share in all major product categories.

• Secured Joint venture partnership with global leader in Ophthalmology for co-developing an automated, one handed Intraocular lens injector. Conducted marketing analysis on potential market size and analyzed competitive environment. Determined the optimal market pricing and conducted KOL interviews to outline key product performance criteria. ALCON LABORATORIES, A Novartis Company, Dallas, TX 2009 – 2012 Globally #1 player within ophthalmic business with revenues of + $10 B and operations in over 94 countries. Global Head, Alliances and Corporate Business Development – Pharmaceutical, Diagnostics and Medical Devices Responsible for defining the strategic direction of +$5 B Consumer and Surgical businesses. Executed growth strategies through Alliances, M&A and Market Development initiatives. Led an organization of 8 direct and indirect reports.

• Developed Mid-Tier IOL strategy to enter emerging markets within Medical device business. Analyzed players within business landscape and made recommendations to acquire target in the high growth Indian market.

• Led Glaucoma platform portfolio strategy to enter Surgical Glaucoma. Analyzed treatment paradigm and unmet medical needs, response strategy and research target. Developed business case, detailed landscape based on research target. Outlined prioritized criteria for ideal treatment profile and selection criteria for ideal technology. Evaluated and recommended technologies for acquisition by conducting analysis for inclusion into Surgical portfolio.

• Evaluated over 50 + Ophthalmic opportunities. Led Alliances group in Search, Evaluation, Negotiation and Alliance management process (SENA). Completed multiple deals involving, strategic partnerships, alliances, licensing intellectual property and joint development agreements, including drug delivery via innovative medical devices and consumables. TARIQ F. AZIZ 1300 Keller Parkway, Apt. 2323, Keller, TX 76248 • 404-***-**** • adqxuw@r.postjobfree.com, page 2 CIBA VISION CORPORATION, NOVARTIS Consumer Health, A.G, Atlanta, GA 2002 – 2009 Globally #2 player within Consumer Vision care business with revenues of + $2 B and operations in over 70 countries. Vice President, Strategy and Business Development, Diagnostics and Medical Devices, (2008 – 2009) General Manager / President, Latin American Operations (Marketing and Sales), Mexico City, Mexico, (2006 – 2008) Vice President, Global Strategy, Consumer, Pharmaceutical and Medical Devices, (2002 – 2005) Reported to CEO. Member CIBA Vision Executive and Operating Committees. Held senior roles in General Management, Global Corporate Strategy, M&A and New Business and Markets Development. Also held role of Chief of Staff for office of CEO implementation of strategic initiatives globally. Accelerated growth in Asia-pacific, Europe and Emerging Markets via developing and implementing go-to-market strategies and new business development. Rated among top 1% NVS executive. Led an organization of 6 direct reports and another 8 indirect reports. General Management; New Business and Markets Development

• Led crucial business growth initiative, with CEO. Developed and executed key strategies leading to global portfolio optimization and identification of growth initiatives in new markets. Developed and executed long term and short-term business plan and objectives delivering sales increase of +$400 MM (+8% CAGR) while improving operating margin by

+70% (EBIT improved from 10% to +17%) in 3 years resulting in increased market share by +2.5 points.

• Latin America: Managed strategic direction and operational execution of $ 200 MM business with full P&L responsibility for sales. Led 10+ countries, organization totaling 130 people with 12 direct reports. Delivered +20% growth and increased operating margins +3 points in 2007 by improving product mix, driving partnership with retail chain accounts and restructured organization to focus on key accounts. Launched Dailies Aqua daily disposable lens behind new marketing campaign exceeding 2007 sales target by 60%. Increased overall market share by +3 points. Corporate Strategic Planning

• Led CIBA Vision 5-year corporate strategic plan, integrating global brand and marketing strategy, innovation and supply chain plans. Integrated input from commercial / regional teams and operating business units. Secured approval for 5-year

$700 MM capital investment plan from Novartis Board of Directors, by establishing financial and operational benefits.

• Developed and implemented a new Competitive Intelligence business function to benchmark internal performance vs. competition. Analyzed market trends and key competitor developments, including innovation profile and cost structure.

• Launched “Office of Strategy Management”, an extension of the office of CEO for strategy implementation and operational monitoring. Developed and managed global Balanced Scorecard / KPI’s to monitor performance against strategic initiatives. Advised on and aligned business unit strategy with overall Corporate Strategy. Lead coordination of key planning activities and processes – Capital planning, 5-year forecasting, budgeting and resource allocation strategy

• Developed market entry strategy for China. Negotiated forming a partnership with a local player in Chinese market, via acquiring stake + $300 MM valuation. Led due diligence within cross functional and highly matrixed environment.

• Built global footprint through developing and implementing Emerging Markets Strategy. Increased sales to 8% of sales, up from 1% in 2002 via developing partnerships/alliances with OEM players, retailers, distributors in Japan and EGM – India, Russia, LATAM. Structured deals with clear milestones to maximize revenue potential, creating joint wins. Global M&A, Corporate Business Development, Alliances and Partnerships

• Developed CIBA Vision’s 3-year Business Development strategy. Conducted extensive reviews of over 20 opportunities based on unmet needs including developing business cases to analyze potential for business development/M&A/alliances. Deal structures included acquiring equity interest, licensing-in; joint development, revenue sharing and royalty. Instituted a best in class M&A and Business Development function / process at CIBA via benchmarking best practices.

• Implemented “Business Development Accelerator”, a stage-gate based process, to evaluate and license breakthrough technologies. Managed all facets of process – screening and analyzing, due diligence, negotiations and deal execution.

• Led acquisition / post-merger integration for a $800 MM acquisition of a global colored contact lens business unit. Acquisition led to CIBA Vision becoming the #1 player in colored contact lenses, achieving + 70% share of segment. Achieved $120 MM in cost synergies via business integration.

• Executed business development deals with research and educational institutions to develop new technologies (e.g. drug delivery). Co-Lead IPSC (Intellectual Property Steering Committee) meetings to ensure effective and efficient management of IP. Negotiated royalties based on SiHy patent infringement with Bausch & Lomb and Cooper Companies.

• Divested Specialty Lens and Surgical business units, with assets of + $70 MM and sales of +$100 MM. Developed CIM and teaser. Led a cross functional team composed of business unit and functional leadership to develop virtual data room. Conducted management presentations to both financial and strategic buyers. Deal structure included royalties plus cash and built in reps and warranties as well as indemnification obligations to increase deal value. Deal size +$150MM.

• Built strong external network / relationships with Investment Banks, Venture Capital, startups and research organizations. Recruited and developed a high impact Strategy and Business Development team. Coached and mentored direct reports. TRANSORA, Chicago, IL 2000 – 2002

A global, open, standards-based, industry-led marketplace formed by 58 FMCG companies - Coca-Cola, P&G, Nestle, Pepsi Global Head - Strategic Planning and Corporate Business Development Reported to Chief Strategy Officer.

TARIQ F. AZIZ 1300 Keller Parkway Apt. 2323, Keller, TX 76248 • 404-***-**** • adqxuw@r.postjobfree.com, page 3

• Led development of a strategic portfolio analysis process to guide CEO and Board of Directors in deployment of resources relative to short and long-term business objectives. Structured a stage gate process to provide a comprehensive framework for evaluating business development opportunities in North America, Europe and Asian markets. FORD MOTOR COMPANY, Detroit, MI 1997- 2000

CONSUMERCONNECT, (a fully owned subsidiary of FORD MOTOR COMPANY) Director –Strategy and Corporate Business Development, (1999 – 2000) Reported to CFO and Executive Director, Corporate Development. A $1.0 Billion B2B Start-up subsidiary focused on developing and commercializing Ford’s leading-edge product, distribution and e-commerce strategies. Strategy and Corporate Business Development – M&A, JV, Partnerships, Alliances

• Established Covisint, the largest on-line B2B exchange in the world, formed through negotiating strategic alliance between Ford, GM, DCX, Oracle and Commerce One. Coordinated in the development of an integrated business plan. Secured initial investment of + $250 MM from founding partners.

• Instrumental in launching and setting-up Consumer Connect Europe. Led development of business plan and directed team to identify new channels for direct sales and distribution. Negotiated highly complex partnerships with technology and OEM partners. Acquired controlling interest in Drive, Microsoft MSN CarPoint, Percept@-TeleTech and Ford Direct ventures. Total portfolio value $350+ MM. Managed and reported P&L for JV’s with controlling stake.

• Developed creative structures and led negotiations to form and acquire majority interest (85% equity interest) in Wingcast, Inc., a telematics joint venture between Ford Motor Company and Qualcomm to provide a wireless based in- vehicle communication and navigation system. Developed business and revenue models to secure funding. Negotiated and closed deal with target company – Deal valued at +$200 MM. FORD OF EUROPE, London, UK/ Cologne, Germany

Senior Manager – Strategy, M&A and New Markets Development, (1997 – 1999) European lead for M&A and New Markets development. Reported to Executive Director. Recruited by CFO Ford Motor Company as part of a highly selective “Accelerated Development Program”, designed to develop outstanding individuals for fast track management positions (only two candidates selected in U.S). Promoted 3 times in three years. M&A, General Management and Emerging Markets Business Development

• Created and managed JV’s in New and Emerging Markets (NEM). Responsible for full P&L management of multinational joint ventures in India (MFIL), Latin America, Russia and South Africa (SAMCOR). Led organization through the launch of first low cost Ford passenger vehicle manufactured in India, resulting in threefold increase in sales, the capture of 10% share of segment.

• Core team member for Ford’s acquisition of entire line of Land Rover business from BMW – Deal value $2.73 B. Developed business case, valuation models, acquisition strategy and negotiated key terms. Member of business integration team, integrating Land Rover line of business into Ford’s Premier Automotive group, realizing over $300 MM in cost synergies.

• Reviewed as part of a cross-functional team, NA and European product portfolio strategy. Recommended market entry and exit strategies, realizing $200 MM in incremental profits through reinvestments and divestitures. Advised CFO on divesting two major product lines, Escort and Scorpio in North America and Europe. TOWERS PERRIN, New York, NY 1996 – 1997

Senior Consultant – Strategy and General Management Consulting Reported to Managing Partner, Health Care Strategy Practice Group.

• Devised strategic plan and conducted market analysis of the changing healthcare system in Europe for a major healthcare client. Identified and established critical change trigger points for client to proactively manage and drive healthcare prescription services in Europe. Developed key performance metrics, for MCOs, to be used in monitoring and grading pharmaceutical firms in the managed care market.

EDUCATION

HARVARD BUSINESS SCHOOL, Boston, MA

Advanced Management and Development Program, 2004-2006 CARNEGIE MELLON UNIVERSITY, Pittsburgh, PA

MBA, General Management and Finance, 1996

NORTH CAROLINA STATE UNIVERSITY, Raleigh, NC

Master of Science, Engineering Management and Operations Research N.E.D UNIVERSITY OF ENGINEERING AND TECHNOLOGY, Karachi, PK Bachelor of Science, Engineering

ADDITIONAL

Member Board of Directors, Atlanta, GA

BioCure, Inc., A medical device start-up, 2005 – 2009

Contact this candidate